Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways

22 Sept 2015

Abstract excerpt

// Elisa Stellaria Grassi 1 , Valeria Vezzoli 1 , Irene Negri 2,7 , Árpád Lábadi 3 , Laura Fugazzola 4,5 , Giovanni Vitale 1,2,6 and Luca Persani 1,2,6 1 DISCCO, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy 2 Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Italy 3 Department of Laboratory Medicine, University of Pécs,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Histone Deacetylase Inhibitors Research
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26415230
DOI: 10.18632/oncotarget.5799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathwaysPMID 26415230Read ↗

Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors.Semantic proximity Read ↗

Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathwaySemantic proximity Read ↗

NVP-BEZ235 inhibits thyroid cancer growth by p53- dependent/independent p21 upregulationSemantic proximity Read ↗

SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibitionSemantic proximity Read ↗

HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid CancerSemantic proximity Read ↗

TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cellsSemantic proximity Read ↗

PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migrationSemantic proximity Read ↗

Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells.Semantic proximity Read ↗

The PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutations.Semantic proximity Read ↗

YAP/TAZ interacts with RBM39 to confer resistance against indisulamSemantic proximity Read ↗

p53-Driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylationSemantic proximity Read ↗

New Insights in Thyroid Cancer and p53 Family Proteins.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.